A 1 GLU 2 -3.573 -3.392 <=B
A 2 LEU 10 -6.260 -6.690
A 3 PRO 4 -5.974 -5.747
A 4 PRO 2 -7.159 -6.566
A 5 LEU 19 -9.090 -10.229
A 6 LYS 1 -8.739 -7.849
A 7 LEU 20 -10.094 -11.233
A 8 MET 13 -9.280 -9.708
A 9 HIS 19 -9.778 -10.838
A 10 SER 0 -9.961 -8.816
A 11 PHE 14 -10.863 -11.224
A 12 CYS 21 -12.583 -13.551
A 13 ALA 7 -10.762 -10.329
A 14 PHE 19 -11.184 -12.082
A 15 LYS 3 -10.687 -9.803
A 16 ALA 24 -11.010 -12.504
A 17 ASP 14 -9.726 -10.218
A 18 ASP 12 -8.851 -9.213
A 19 GLY 22 -7.943 -9.559
A 20 PRO 1 -4.135 -3.774
A 21 CYS 13 -5.202 -6.099
A 22 LYS 0 -3.295 -2.916 <=B
A 23 ALA 12 -5.464 -6.216
A 24 ILE 0 -6.125 -5.421
A 25 MET 21 -7.902 -9.409
A 26 LYS 6 -8.246 -7.988
A 27 ARG 26 -10.597 -12.369
A 28 PHE 18 -11.865 -12.571
A 29 PHE 24 -12.895 -14.172
A 30 PHE 23 -13.041 -14.187
A 31 ASN 10 -11.835 -11.624
A 32 ILE 14 -10.047 -10.501
A 33 PHE 4 -8.997 -8.423
A 34 THR 12 -8.954 -9.304
A 35 ARG 8 -9.815 -9.607
A 36 GLN 4 -10.128 -9.423
A 37 CYS 22 -12.157 -13.289
A 38 GLU 13 -11.310 -11.504
A 39 GLU 3 -10.588 -9.716
A 40 PHE 25 -10.561 -12.221
A 41 ILE 6 -8.714 -8.402
A 42 TYR 21 -8.893 -10.286
A 43 GLY 11 -8.060 -8.398
A 44 GLY 6 -8.123 -7.879
A 45 CYS 4 -8.046 -7.581
A 46 GLU 6 -7.670 -7.478
A 47 GLY 27 -8.668 -10.776
A 48 ASN 14 -9.563 -10.073
A 49 GLN 10 -10.115 -10.101
A 50 ASN 24 -11.828 -13.227
A 51 ARG 18 -11.553 -12.294
A 52 PHE 25 -11.496 -13.049
A 53 GLU 0 -9.438 -8.353
A 54 SER 3 -9.998 -9.193
A 55 LEU 5 -10.559 -9.920
A 56 GLU 0 -8.742 -7.737
A 57 GLU 12 -9.911 -10.151
A 58 CYS 25 -12.832 -14.232
A 59 LYS 4 -9.786 -9.121
A 60 LYS 7 -8.826 -8.616
A 61 MET 24 -10.323 -11.895
A 62 CYS 29 -11.727 -13.713
A 63 THR 19 -10.137 -11.156

Identified 2 B-Cell epitope residues out of 63 total residues